Virtual event

The political issues circling the FDA this year could potentially ripple into biopharma on a scale that’s never been seen before. All eyes are on the FDA’s response to recent court rulings around the abortion pill mifepristone — and the potential effects on other approvals that might be questioned. What does the future look like, exactly? Join Endpoints’ Senior Editor Zachary Brennan in an expert panel to unpack what may come next.

Jun 26, 2023
2:00 - 3:30pm ET
Virtual event
0
Days
0
Hours
0
Min
0
Sec
pm ET

Fireside chat with Zachary Brennan

A one-on-one conversation with Zachary Brennan, Senior Editor at Endpoints, and an industry leader discussing all things drug pricing, PBMs, legislative reforms and implementation of the IRA.

Antonio Ciaccia

Antonio Ciaccia

CEO, Secretary

46brooklyn Research

Zachary Brennan

Zachary Brennan

Senior Editor

Endpoints News

pm ET

Ripple effect: FDA & the abortion drug court saga

What can biopharma companies expect from the recent court rulings around the abortion pill mifepristone and FDA's reaction?

David S. Cohen

David S. Cohen

Professor of Law

Drexel University Kline School of Law

Joanne Rosen

Joanne Rosen

Senior Lecturer Co-Director, Center for Law and the Public’s Health

Johns Hopkins Bloomberg School of Public Health

Eric Reinhart

Eric Reinhart

Physician-Anthropologist of Public Health and Law

Northwestern University

Zachary Brennan

Zachary Brennan

Senior Editor

Endpoints News

For sponsorship opportunities contact rmcrae@endpts.com

Register now

No cost to register, subject to confirmation. By registering for this event, you accept that you may receive direct communication from the sponsor(s). If you are experiencing problems with your registration, please contact our support team.